Prudential Financial’s Neuronetics STIM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-15,200
Closed -$55.9K 2508
2025
Q1
$55.9K Buy
+15,200
New +$55.5K ﹤0.01% 2187
2024
Q3
Sell
-20,400
Closed -$36.7K 2793
2024
Q2
$36.7K Sell
20,400
-1,200
-6% -$3.46K ﹤0.01% 2645
2024
Q1
$103K Sell
21,600
-800
-4% -$2.81K ﹤0.01% 2528
2023
Q4
$65K Hold
22,400
﹤0.01% 2526
2023
Q3
$30.2K Buy
22,400
+9,000
+67% +$15.8K ﹤0.01% 2546
2023
Q2
$28.8K Buy
+13,400
New +$32.5K ﹤0.01% 2588
2023
Q1
Sell
-12,400
Closed -$85.2K 2668
2022
Q4
$85.2K Sell
12,400
-1,800
-13% -$8.5K ﹤0.01% 2459
2022
Q3
$45K Buy
+14,200
New +$51.6K ﹤0.01% 2562

Other funds holding STIM

Prudential Financial's STIM Position: Q2 2025 in Review

Prudential Financial sold out of Neuronetics (STIM) in Q2 2025, closing a stake of 15,200 shares — an estimated $55.9K sold.

Prudential Financial first reported a position in STIM in Q3 2022 and held it in 8 quarters. The position peaked at $103K in Q1 2024. 90 funds tracked by Wall St. Rank hold STIM as of Q2 2025.

  • Prudential Financial reported no remaining Neuronetics position as of Q2 2025 after selling out during the quarter.
  • Prudential Financial sold 15,200 Neuronetics shares in Q2 2025, an estimated $55.9K.
  • Prudential Financial first reported a position in Neuronetics in Q3 2022 and held it in 8 quarters.
  • Prudential Financial's Neuronetics position peaked at $103K in Q1 2024.
  • 90 funds tracked by Wall St. Rank held Neuronetics as of Q2 2025.

Based on Prudential Financial's 13F filing for Q2 2025, filed 12 Aug 2025.